The cash and stock transaction is expected to expand Mallinckrodt’s offerings of specialty pharmaceuticals, primarily Questcor’s drug Acthar, which is used to manage autoimmune and inflammatory conditions.
via NYT > Business Day http://ift.tt/1oHv8mK
via WordPress http://ift.tt/1g1mQwB
via All Business Is Good Business http://ift.tt/1kk0LB2
via May 21st 2011 wrong http://ift.tt/QYgusC
No comments:
Post a Comment